or Try an Advanced Search...

    Technical Analysis for ETNB - 89bio, Inc.

    Grade Last Price % Change Price Change
    D 8.53 6.89% 0.55
    ETNB closed down 0.13 percent on Wednesday, November 20, 2024, on 89 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Down
    Historical ETNB trend table...
    Date Alert Name Type % Chg
    Hammer Candlestick Bullish 6.89%
    Lizard Bullish Bullish Day Trade Setup 6.89%
    Outside Day Range Expansion 6.89%
    Wide Bands Range Expansion 6.89%
    Oversold Stochastic Weakness 6.89%
    NR7 Range Contraction 6.76%
    NR7-2 Range Contraction 6.76%
    Narrow Range Bar Range Contraction 6.76%
    Wide Bands Range Expansion 6.76%
    Oversold Stochastic Weakness 6.76%
    Older End-of-Day Signals for ETNB ...

       Recent Intraday Alerts

    Alert Time
    Up 5% 39 minutes ago
    Up 3% about 1 hour ago
    Rose Above 50 DMA about 1 hour ago
    50 DMA Resistance about 1 hour ago
    Up 2% about 1 hour ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ETNB Chart by TradingView
    Basic chart:

    Profile

    89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Alcohol Metabolic Disease Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease Innovative Therapies

    Is ETNB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting® 2024
    Nov 13 89bio drops 2%, prices $125M stock offering
    Nov 13 89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants
    Nov 12 89bio announces proposed underwritten public offering of common stock and pre-funded warrants
    Nov 12 89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
    Nov 8 89bio GAAP EPS of -$1.39 misses by $0.78
    Nov 7 89bio Reports Third Quarter 2024 Financial Results and Corporate Updates
    Nov 5 89bio to Participate in the UBS Global Healthcare Conference
    Nov 2 Madrigal, 89Bio jump after Novo’s semaglutide shows promise in MASH
    Nov 1 Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH
    See more ETNB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 16.63
    52 Week Low 7.0
    Average Volume 757,514
    200-Day Moving Average 9.07
    50-Day Moving Average 8.17
    20-Day Moving Average 8.72
    10-Day Moving Average 8.91
    Average True Range 0.62
    RSI (14) 42.86
    ADX 24.98
    +DI 17.41
    -DI 28.71
    Chandelier Exit (Long, 3 ATRs) 8.85
    Chandelier Exit (Short, 3 ATRs) 9.54
    Upper Bollinger Bands 10.48
    Lower Bollinger Band 6.97
    Percent B (%b) 0.29
    BandWidth 40.22
    MACD Line 0.02
    MACD Signal Line 0.22
    MACD Histogram -0.1999
    Fundamentals Value
    Market Cap 743.78 Million
    Num Shares 93.2 Million
    EPS -1.80
    Price-to-Earnings (P/E) Ratio -4.43
    Price-to-Sales 0.00
    Price-to-Book 1.92
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 8.57
    Resistance 3 (R3) 8.54 8.30 8.47
    Resistance 2 (R2) 8.30 8.15 8.32 8.44
    Resistance 1 (R1) 8.14 8.06 8.03 8.18 8.41
    Pivot Point 7.91 7.91 7.85 7.93 7.91
    Support 1 (S1) 7.75 7.76 7.63 7.78 7.55
    Support 2 (S2) 7.51 7.66 7.53 7.52
    Support 3 (S3) 7.35 7.51 7.49
    Support 4 (S4) 7.39